A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CWK SEC filings page.
Cushman & Wakefield Ltd. (CWK) reported $11.0B in revenue over the twelve months to Sep 30, 2026, up 10.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 shows the business converting stronger operating performance into cash while reducing long-term leverage despite thinner bottom-line earnings.
From FY2024 to FY2025, operating income rose33.5% while net income fell32.8% , separating operating improvement from bottom-line earnings. Operating cash flow nevertheless reached$340M and free cash flow$293M , indicating that cash generation outpaced reported profit.
Revenue expanded
Long-term debt declined
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cushman & Wakefield Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Cushman & Wakefield Ltd. scores 51/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Cushman & Wakefield Ltd. scores 45/100 on it among other operating companies.
Cushman & Wakefield Ltd.'s net debt of $1.8B, being $2.6B of long-term debt less $784.2M of cash, came to 3.31 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Cushman & Wakefield Ltd. scores 18/100 among other operating companies.
Cushman & Wakefield Ltd. held $1.10 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.10. Liquidity ranks operating companies on that ratio, and Cushman & Wakefield Ltd. scores 25/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Cushman & Wakefield Ltd. scores 35/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Cushman & Wakefield Ltd. scores 60/100 on it among other operating companies.
Cushman & Wakefield Ltd. scores 1.74, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $897.7M against total assets of $7.7B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cushman & Wakefield Ltd. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, Cushman & Wakefield Ltd. generates $3.86 in operating cash flow ($340.4M OCF vs $88.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Cushman & Wakefield Ltd. earns $2.09 in operating income for every $1 of interest expense ($452.5M vs $216.2M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Cushman & Wakefield Ltd. generated $2.8B in revenue in Q3 2026. This represents an increase of 7.7% from the same quarter a year earlier. Against the prior quarter it is up 1.6%.
Cushman & Wakefield Ltd.'s EBITDA was $156.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.6% from the same quarter a year earlier. Against the prior quarter it is down 3.7%.
Cushman & Wakefield Ltd. reported $52.1M in net income in Q3 2026. This represents an increase of 1.4% from the same quarter a year earlier. Against the prior quarter it is down 1.1%.
Cushman & Wakefield Ltd. earned $0.22 per diluted share (EPS) in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Cash & Balance Sheet
Cushman & Wakefield Ltd. generated $176.1M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 21.7% from the same quarter a year earlier. Against the prior quarter it is up 287.0%.
Cushman & Wakefield Ltd. held $489.0M in cash against $2.4B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Cushman & Wakefield Ltd.'s gross margin was 17.3% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.2 percentage points.
Cushman & Wakefield Ltd.'s operating margin was 4.6% in Q3 2026, reflecting core business profitability. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.
Cushman & Wakefield Ltd.'s net profit margin was 1.9% in Q3 2026, showing the share of revenue converted to profit. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.
Cushman & Wakefield Ltd.'s quarterly ROE was 2.5% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.
Capital Allocation
Cushman & Wakefield Ltd. invested $37.8M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 260.0% from the same quarter a year earlier. Against the prior quarter it is up 344.7%.
Not reported for Q3 2026.
Not reported for Q3 2026.
CWK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B+7.7% | $2.8B+11.2% | $2.5B+11.0% | $2.9B+10.8% | $2.6B+11.2% | $2.5B+8.6% | $2.3B+4.6% | $2.6B+3.0% |
| Cost of Revenue | $2.3B+7.9% | $2.3B+11.6% | $2.1B+11.3% | $2.3B+11.3% | $2.2B+12.6% | $2.0B+7.6% | $1.9B+3.7% | $2.1B+1.3% |
| Gross Profit | $486.3M+7.1% | $512.0M+9.6% | $420.7M+9.5% | $574.5M+8.7% | $453.9M+5.0% | $467.3M+13.1% | $384.3M+9.1% | $528.4M+10.4% |
| SG&A Expenses | $329.6M+2.8% | $349.3M+9.7% | $336.7M+10.1% | $372.5M+16.5% | $320.6M+2.0% | $318.3M+8.2% | $305.8M+3.3% | $319.7M+0.8% |
| Operating Income | $129.9M+20.8% | $134.2M+9.3% | $58.7M+29.6% | $176.9M+1.4% | $107.5M+43.0% | $122.8M+74.4% | $45.3M+141.0% | $174.5M+58.6% |
| EBITDA | $156.7M+17.6% | $162.7M+9.2% | $84.0M+16.7% | $202.4M-0.8% | $133.3M+28.0% | $149.0M+46.7% | $72.0M+40.4% | $204.1M+39.0% |
| Interest Expense | $49.2M-12.1% | $59.6M+12.0% | $49.2M-5.9% | $54.7M-1.4% | $56.0M+2.0% | $53.2M-12.5% | $52.3M-10.9% | $55.5M-2.5% |
| Income Tax | $31.6Mn/m | $24.6M+30.2% | $3.0M-3.2% | $10.3M-46.4% | -$6.3M-132.6% | $18.9M+410.8% | $3.1M+34.8% | $19.2M+6300.0% |
| Net Income | $52.1M+1.4% | $52.7M-8.0% | -$12.6M-763.2% | -$22.4M-119.8% | $51.4M+52.5% | $57.3M+324.4% | $1.9Mn/m | $112.9M+61.7% |
| EPS (Basic) | $0.220.0% | $0.22-12.0% | -$0.05-600.0% | -$0.10-120.4% | $0.22+46.7% | $0.25+316.7% | $0.01n/m | $0.49+63.3% |
| EPS (Diluted) | $0.220.0% | $0.22-12.0% | -$0.05-600.0% | -$0.09-118.8% | $0.22+57.1% | $0.25+316.7% | $0.01n/m | $0.48+60.0% |
| Diluted Shares (Avg) | 237M+0.6% | 236M+1.7% | 233M+0.2% | N/A | 236M+1.1% | 232M+0.4% | 232M+1.9% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
CWK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.7B+0.7% | $7.6B0.0% | $7.6B+3.2% | $7.7B+1.7% | $7.7B+2.1% | $7.6B+2.9% | $7.4B-1.1% | $7.5B-2.9% |
| Current Assets | $2.7B+1.7% | $2.6B-0.4% | $2.7B+5.5% | $2.8B+5.7% | $2.7B+0.9% | $2.6B+1.7% | $2.6B+5.9% | $2.7B-4.0% |
| Cash & Equivalents | $489.0M-22.9% | $500.5M-19.0% | $600.6M-3.6% | $784.2M-1.1% | $634.4M-18.2% | $618.2M+9.0% | $623.2M+12.6% | $793.3M+3.3% |
| Short-Term Investments | N/A | N/A | N/A | N/A | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | N/A | N/A | N/A | N/A | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $2.1B+0.1% | $2.1B-0.1% | $2.1B+1.9% | $2.1B+3.0% | $2.1B+0.3% | $2.1B+1.8% | $2.0B-2.1% | $2.0B-4.0% |
| Total Liabilities | $5.6B-1.6% | $5.5B-2.1% | $5.7B+1.2% | $5.7B-1.3% | $5.7B-1.7% | $5.7B-0.9% | $5.6B-4.0% | $5.8B-5.0% |
| Current Liabilities | $2.6B+2.0% | $2.4B+4.8% | $2.4B+10.1% | $2.6B+11.2% | $2.5B+11.8% | $2.3B+8.9% | $2.2B+1.1% | $2.3B-2.8% |
| Non-Current Liabilities | $3.1B-4.3% | $3.1B-6.9% | $3.3B-4.6% | $3.1B-9.7% | $3.2B-10.1% | $3.3B-6.8% | $3.4B-7.0% | $3.5B-6.4% |
| Long-Term Debt | $2.4B-11.3% | $2.4B-14.4% | $2.6B-9.9% | $2.6B-10.7% | $2.7B-9.2% | $2.8B-6.0% | $2.9B-5.1% | $2.9B-5.1% |
| Total Equity | $2.1B+7.2% | $2.0B+6.2% | $2.0B+9.9% | $2.0B+11.4% | $2.0B+15.0% | $1.9B+16.1% | $1.8B+9.3% | $1.8B+4.6% |
| Retained Earnings | -$805.5Mn/m | -$857.6Mn/m | -$910.3Mn/m | -$897.7Mn/m | -$875.3Mn/m | -$926.7Mn/m | -$984.0Mn/m | -$985.9Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable.
CWK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $213.9M-9.2% | $54.0M+462.5% | -$243.5Mn/m | $257.3M+123.4% | $235.5M+20.1% | $9.6M-56.0% | -$162.0Mn/m | $115.2M-43.1% |
| Depreciation & Amortization | $26.8M+3.9% | $28.5M+8.8% | $25.3M-5.2% | $25.5M-13.9% | $25.8M-10.7% | $26.2M-16.0% | $26.7M-17.8% | $29.6M-19.6% |
| Stock-Based Compensation | N/A | N/A | $16.3M+1.9% | N/A | N/A | N/A | $16.0M+150.0% | N/A |
| Capital Expenditures | $37.8M+260.0% | $8.5M-8.6% | $12.2M+165.2% | $23.0M+147.3% | $10.5M+11.7% | $9.3M-21.2% | $4.6M-56.2% | $9.3M-42.6% |
| Free Cash Flow | $176.1M-21.7% | $45.5M+15066.7% | -$255.7Mn/m | $234.3M+121.2% | $225.0M+20.5% | $300K-97.0% | -$166.6Mn/m | $105.9M-43.1% |
| Investing Cash Flow | -$163.2Mn/m | -$35.9M-441.9% | $94.1M+356.8% | $7.9Mn/m | -$60.1M-204.7% | $10.5M-84.5% | $20.6Mn/m | -$33.1Mn/m |
| Financing Cash Flow | -$61.9Mn/m | -$116.1Mn/m | -$28.1Mn/m | -$117.4Mn/m | -$155.5Mn/m | -$36.3Mn/m | -$41.3Mn/m | -$55.9Mn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CWK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.3%-0.1pp | 18.5%-0.3pp | 16.6%-0.2pp | 19.7%-0.4pp | 17.4%-1.0pp | 18.8%+0.7pp | 16.8%+0.7pp | 20.1%+1.4pp |
| Operating Margin | 4.6%+0.5pp | 4.9%-0.1pp | 2.3%+0.3pp | 6.1%-0.6pp | 4.1%+0.9pp | 4.9%+1.9pp | 2.0%+1.1pp | 6.6%+2.3pp |
| Net Margin | 1.9%-0.1pp | 1.9%-0.4pp | -0.5%-0.6pp | -0.8%-5.1pp | 2.0%+0.5pp | 2.3%+1.7pp | 0.1%+1.4pp | 4.3%+1.6pp |
| Return on Equity | 2.5%-0.2pp | 2.6%-0.4pp | -0.7%-0.8pp | -1.1%-7.6pp | 2.6%+0.6pp | 3.0%+2.2pp | 0.1%+1.9pp | 6.4%+2.3pp |
| Return on Assets | 0.7%0.0pp | 0.7%-0.1pp | -0.2%-0.2pp | -0.3%-1.8pp | 0.7%+0.2pp | 0.8%+0.6pp | 0.0%+0.4pp | 1.5%+0.6pp |
| Current Ratio | 1.060.0x | 1.08-0.1x | 1.130.0x | 1.10-0.1x | 1.07-0.1x | 1.13-0.1x | 1.18+0.1x | 1.150.0x |
| Debt-to-Equity | 1.15-0.2x | 1.19-0.3x | 1.34-0.3x | 1.34-0.3x | 1.39-0.4x | 1.48-0.3x | 1.64-0.2x | 1.68-0.2x |
| Liabilities-to-Equity | 2.69-0.2x | 2.74-0.2x | 2.92-0.3x | 2.93-0.4x | 2.93-0.5x | 2.97-0.5x | 3.17-0.4x | 3.30-0.3x |
| Asset Turnover | 0.360.0x | 0.370.0x | 0.330.0x | 0.380.0x | 0.340.0x | 0.330.0x | 0.310.0x | 0.350.0x |
| FCF Margin | 6.3%-2.4pp | 1.7%+1.6pp | -10.1%-2.8pp | 8.0%+4.0pp | 8.6%+0.7pp | 0.0%-0.4pp | -7.3%-1.1pp | 4.0%-3.3pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cushman & Wakefield Ltd. CWK | FY2025 | $10.3B | $88.2M | 0.9% | $3.1B | 39/100 |
| IHS Holding Limited IHS | FY2025 | $1.6B | $143.6M | 9.1% | $2.8B | 55/100 |
| Colliers International Group Inc. CIGI | FY2025 | $5.6B | $103.1M | 1.8% | $4.6B | 45/100 |
| FirstService Corporation FSV | FY2025 | $5.5B | $145.0M | 2.6% | $6.5B | 57/100 |
| Compass, Inc. COMP | FY2025 | $7.0B | -$58.5M | -0.8% | $7.8B | 48/100 |
| Newmark Group, Inc. NMRK | FY2025 | $3.3B | $126.2M | 3.8% | $1.9B | 43/100 |
Where Cushman & Wakefield Ltd. Ranks
Frequently Asked Questions
Cushman & Wakefield Ltd. (CWK) reported $10.3B in total revenue for fiscal year 2025. This represents a 8.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Cushman & Wakefield Ltd. (CWK) revenue grew by 8.9% year-over-year, from $9.4B to $10.3B in fiscal year 2025.
Yes, Cushman & Wakefield Ltd. (CWK) reported a net income of $69.8M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $88.2M, with a net profit margin of 0.9%.
Cushman & Wakefield Ltd. (CWK) had EBITDA of $556.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Cushman & Wakefield Ltd. (CWK) had $784.2M in cash and equivalents against $2.6B in long-term debt.
Cushman & Wakefield Ltd. (CWK) had a gross margin of 18.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Cushman & Wakefield Ltd. (CWK) had an operating margin of 4.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Cushman & Wakefield Ltd. (CWK) had a net profit margin of 0.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Cushman & Wakefield Ltd. (CWK) has a return on equity of 4.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Cushman & Wakefield Ltd. (CWK) generated $293.0M in free cash flow during fiscal year 2025. This represents a 75.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Cushman & Wakefield Ltd. (CWK) generated $340.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Cushman & Wakefield Ltd. (CWK) had $7.7B in total assets as of fiscal year 2025, including both current and long-term assets.
Cushman & Wakefield Ltd. (CWK) invested $47.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Cushman & Wakefield Ltd. (CWK) had a current ratio of 1.10 as of fiscal year 2025, which is considered adequate.
Cushman & Wakefield Ltd. (CWK) had a debt-to-equity ratio of 1.34 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Cushman & Wakefield Ltd. (CWK) had a liabilities-to-equity ratio of 2.93 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Cushman & Wakefield Ltd. (CWK) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Cushman & Wakefield Ltd. (CWK) trades at 44.7x earnings, its market capitalization divided by $69.8M net income, trailing 12 months to September 30, 2026. The market capitalization is $3.1B as of Nov 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Cushman & Wakefield Ltd. (CWK) trades at 0.3x sales, its market capitalization divided by $11.0B revenue, trailing 12 months to September 30, 2026. The market capitalization is $3.1B as of Nov 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Cushman & Wakefield Ltd. (CWK) has an Altman Z-Score of 1.74, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Cushman & Wakefield Ltd. (CWK) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Cushman & Wakefield Ltd. (CWK) has an earnings quality ratio of 3.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Cushman & Wakefield Ltd. (CWK) has an interest coverage ratio of 2.09x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Cushman & Wakefield Ltd. (CWK) scores 39 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.